membrane protein
[대역어] 막 단백질
[용어속성] Protein
[용어속성] Protein
MALDI-ToF protein profiling as a potential rapid diagnostic platform for COVID-19
Research article
Published on
Journal: Journal of Mass Spectrometry and Advances in the Clinical Lab [Category] 바이오마커, 변종, 진단,
Journal: Journal of Mass Spectrometry and Advances in the Clinical Lab [Category] 바이오마커, 변종, 진단,
[키워드] liquid chromatography mass spectrometry
ACE2angiotensin-converting enzyme 2
Analysis
analyzed
angiotensin-converting enzyme 2
area under the curve
Asymptomatic
AUCarea under the curve
Biomarker
Cohort
Concordance
controls
Coronavirus disease 2019
COVID-19
COVID-19 pandemic
COVID-19 testing
COVID-19coronavirus disease 2019
CT
cycle threshold
demonstrated
develop
diagnostic
Diagnostic method
dithiothreitol
DTTdithiothreitol
E Proteinenvelope protein
Emergency use authorization
envelope protein
EUAemergency use authorization
FDAFood and Drug Administration
Food and Drug Administration
human donor
human serum
IgAimmunoglobulin A
IgGimmunoglobulin G
IgMimmunoglobulin M
immunoglobulin A
Immunoglobulin G
immunoglobulin M
immunoglobulins
inactivated
LC-MS
limit of detection
limitation
LoDlimit of detection
M Proteinmembrane protein
MALDI-ToF MSmatrix-assisted laser desorption/ionization-time of flight mass spectrometry
matrix-assisted laser desorption/ionization-time of flight mass spectrometry
membrane protein
N Proteinnucleocapsid protein
nasopharyngeal
Nasopharyngeal swab
nasopharyngeal swabs
Non-invasive
NPnasopharyngeal
nucleocapsid protein
pilot study
platform
positive individuals
Protein
proteome
RBDReceptor Binding Domain
receiver operating characteristic
Receptor binding domain
Reverse transcriptase quantitative polymerase chain reaction
Ribonucleic acid
RNARibonucleic acid
ROCreceiver operating characteristic
RT-qPCR
S Proteinspike protein
Saliva
SARS-CoV-2
SARS-CoV-2 strains
SARS-CoV-2 virus
SARS-CoV-2severe acute respiratory syndrome coronavirus 2
sensitivity
severe acute respiratory syndrome coronavirus 2
specificity
specimen
Spike protein
VEPviral envelope protein
viral envelope protein
WHOWorld Health Organization
with COVID-19
World Health Organization
[DOI] 10.1016/j.jmsacl.2021.09.001 [Article Type] Research article
[DOI] 10.1016/j.jmsacl.2021.09.001 [Article Type] Research article
T cell-mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19
COVID-19 이전에 간 이식 환자에서 SARS-CoV-2에 대한 T 세포 매개 반응
Article
Published on
Journal: American journal of transplantation : official jou [Category] MERS, SARS, 진단, 치료기술,
Journal: American journal of transplantation : official jou [Category] MERS, SARS, 진단, 치료기술,
[키워드] 1:1
acute respiratory syndrome
age
antigens
CD4
CD8
Cell-mediated immunity
cell-mediated response
clinical research/practice
Complication
complication: infectious
control group
coronavirus
COVID-19
COVID-19 diagnosis
cytokine
declining
Diagnosis
ELISA
ICS
IgG antibodies
IgG responses
immune
immune modulation
Immunosuppression
immunosuppression/immune modulation
impair
Infection
infection and infectious agents
infection and infectious agents - viral
infectious
infectious agent
infectious agents
Infectious disease
interferon
intracellular cytokine staining
inverse correlation
liver
Liver transplantation
liver transplantation/hepatology
magnitude
median
membrane
membrane protein
monitoring: immune.
MOST
no significant difference
no significant differences
p value
Patient
patients
proportion
recipient
recipients
respiratory
response
SARS-CoV-2
SARS-CoV-2 IgG antibody
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
SFU
Spearman
T cell
were measured
[DOI] 10.1111/ajt.16708 PMC 바로가기 [Article Type] Article
[DOI] 10.1111/ajt.16708 PMC 바로가기 [Article Type] Article
Screening Antibodies Raised against the Spike Glycoprotein of SARS-CoV-2 to Support the Development of Rapid Antigen Assays
Article
[키워드] antibody
Antigen
antigens
Asymptomatic case
Biomarker
coronavirus
Coronavirus-2
country
cross-reactivity
detection
development
diagnose
Diagnosis
diagnostic
diagnostic test
diagnostic tests
diagnostic value
disease
early stage
envelope protein
group
identify
immunoassay
immunoassays
include
infected case
Infection
lateral flow
leading
management
membrane protein
molecular
monoclonal antibody
nucleocapsid protein
promote
provided
Rapid
Rapid diagnostic test
Research
resources
SARS-CoV-2
SARS-CoV-2 spike protein
Screening
sensitivity
serologic
serologic tests
spike glycoprotein
Spike protein
Support
Surveillance
the Spike
therapeutic
Transmission
viral pathogen
[DOI] 10.1021/acsomega.1c01321 PMC 바로가기 [Article Type] Article
[DOI] 10.1021/acsomega.1c01321 PMC 바로가기 [Article Type] Article
Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection
새로운 진핵생물 발현과 살모넬라 박토펙션을 혼합한 매우 실현 가능한 면역보호 멀티시스트론 SARS-CoV-2 백신 후보
Article
Published on
Journal: Journal of advanced research [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단,
Journal: Journal of advanced research [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단,
[키워드] Analysis
anti-SARS-CoV-2 immune responses
Antibody titers
antigen-specific antibody
Antiviral
CD4
CD8
Cell-mediated immunity
Cellular immune response
co-expression
COVID-19
Cytometry
demonstrated
determine
develop
DNA
domain
effective
Efficacy
Efficiency
elicited
epitope
Epitopes
eukaryotic
expressing
expression
feasible
Flow
flow cytometry
Frame
fused
gene delivery
heptad repeat
highest
humoral
immune responses
immunized mice
immunofluorescence assay
immunogenicity
IMPROVE
in vivo
increase in
investigated
mechanism
membrane protein
mice
mRNA
Multicistronic expression
multivalent vaccine
neutralizing antibody titers
nsp13
offer
Open reading frame
pandemic
peptide
polarization
Protein
protein expression
raised
RBD
recall
Receptor-binding domain
recorded
RNA
robust
Safe
Salmonella
SARS-CoV-2
SARS-CoV-2 gene
SARS-CoV-2 genes
SARS-CoV-2 neutralizing antibody
SARS-CoV-2 protein
SARS-CoV-2 proteins
SARS-CoV-2 vaccine
SARS-CoV-2 variant
SARS-CoV-2 variants
sera
Spike protein
splenocyte
splenocytes
suggested
T cell
T cells
targets
Th1
Th1 response
Th2 immunity
the spike protein
the vaccine
Vaccine
vaccine candidate
vaccine construct
variant
variants
were used
western blot
Western blot analysis
[DOI] 10.1016/j.jare.2021.07.007 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.jare.2021.07.007 PMC 바로가기 [Article Type] Article
Tagged extracellular vesicles with the RBD of the viral spike protein for delivery of antiviral agents against SARS-COV-2 infection
SARS-COV-2 감염에 대한 항바이러스제 전달을 위한 바이러스 스파이크 단백질의 RBD로 태그가 지정된 세포외 소포
Article
[키워드] accumulate
ACE2
ACE2 receptor
antiviral agent
Antiviral agents
approach
binding domain
Cell
cellular
cellular entry
develop
domain
effective
encapsulate
endocytosed
Express
Extracellular
extracellular vesicle
Extracellular vesicles
fusion
hACE2
highlight
in vivo
Infection
Interaction
lung tissue
lung tissues
membrane
membrane protein
Membrane proteins
modify
molecular
provide
pseudovirus infection
RBD
Receptor binding domain
receptor binding domain (RBD)
Receptor-binding domain
recognize
required
Safe
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 pseudovirus
siRNA
siRNAs
specific tissue
specific tissues
Spike protein
spread of COVID-19
suppress
Tagged
target cells
target tissue
target tissues
targeting
the RBD
the receptor-binding domain
therapeutic potential
Therapeutics
tissue
Transgenic mouse
viral spike protein
[DOI] 10.1016/j.jconrel.2021.05.049 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.jconrel.2021.05.049 PMC 바로가기 [Article Type] Article
Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients
흉부 이식 수혜자의 2회 용량 SARS-CoV-2 메신저 RNA 백신 BNT162b2에 대한 체액 및 T 세포 반응 불량
Original Paper
[키워드] Abbott
age
analysed
anti-SARS-CoV-2
average
BioNTech/Pfizer (BNT162b2) vaccine
blood sample
Blood samples
BNT162b2
BNT162b2 vaccine
booster dose
cellular response
control group
COVID-19 infection
detectable
domain
domains
dose
ELISA
Euroimmun
Evidence
evidence of
excluded
exhibited
functional
Genscript
healthy
heart
humoral
IgG
immune response
immune responses
immunoassays
Immunocompromised patient
Immunocompromised patients
immunogenicity
Immunoglobulin
infectious agent
infectious agents
inhibitory
interferon
interferon-γ
lung
majority
membrane protein
Messenger RNA
Neutralizing antibodies
neutralizing antibody
nucleocapsid
Organ transplant
Patient
patients
peptides
Pfizer-BioNTech
Poor
prime
Qiagen
QuantiFERON
recipient
recipients
robust
SARS-CoV-2
Seroconversion
shown
significant increase
Specific T-cell response
Spike protein
stimulated
T-cell
T-cell Response
tested
titre
Transplant recipients
vaccination
Vaccine
Vaccines
Viral
viral spike
was measured
Whole blood
[DOI] 10.1007/s00392-021-01880-5 PMC 바로가기 [Article Type] Original Paper
[DOI] 10.1007/s00392-021-01880-5 PMC 바로가기 [Article Type] Original Paper
Inhibition of SARS CoV Envelope Protein by Flavonoids and Classical Viroporin Inhibitors
Microbiology
[키워드] acute respiratory syndrome
blocked
buffer
Cell
cell viability assay
classical
conserved
contribute
coronavirus
E protein
Effect
effective
envelope
envelope protein
epigallocatechin
expressed
expression
Extracellular
family Coronaviridae
flavonoid
genus Betacoronavirus
HEK293 cell
inflammasome activation
inhibited
inhibition
inhibitor
inhibitors
inhibitory activity
introduced
involved
ion channel inhibitors
kDa
membrane protein
novel antiviral drug
patch-clamp electrophysiology
plasma membrane
proliferation
Protein
quercetin
RNA virus
SARS CoV
SARS CoV-1
SARS-CoV
SARS-CoV E
SARS-CoV-2
sequence
signal peptide
single-stranded positive-sense
suppress
tested
transfer
transmembrane
viability
viroporins
virus
Virus life cycle
[DOI] 10.3389/fmicb.2021.692423 PMC 바로가기 [Article Type] Microbiology
[DOI] 10.3389/fmicb.2021.692423 PMC 바로가기 [Article Type] Microbiology
Remdesivir Strongly Binds to RNA-Dependent RNA Polymerase, Membrane Protein, and Main Protease of SARS-CoV-2: Indication From Molecular Modeling and Simulations
Pharmacology
[키워드] Analysis
antiviral action
antiviral activity
antiviral drugs
average
bind
binding
binding affinity
Comprehensive
decrease
development
deviation
drug
effective
effort
Favipiravir
indication
inhibiting
main protease
membrane protein
Membrane proteins
MERS-CoV
Middle East
modeling
pathogenic
protease
Protein
reduce
Remdesivir
respiratory syndrome coronavirus
Ritonavir
RNA
RNA-dependent RNA polymerase
SARS-CoV
SARS-CoV-2
shown
Simulation
single-stranded RNA virus
suggested
treatment regimen
[DOI] 10.3389/fphar.2021.710778 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2021.710778 PMC 바로가기 [Article Type] Pharmacology
Recombinant SARS-CoV-2 envelope protein traffics to the trans -Golgi network following amphipol-mediated delivery into human cells
Accelerated Communication
[키워드] acute respiratory syndrome
AF488, Alexa Flour 488
amphipol
antiviral therapies
approach
Cell
cells
cellular
conserved
coronavirus
CoV
CoV, coronavirus
delivery
disrupt
E protein
envelope
envelope protein
ER, endoplasmic reticulum
ERGIC, ER–Golgi complex intermediate compartment
expression
human cell
insertion
ion channel
LAMP1, lysosomal-associated membrane protein 1
Lysosomes
membrane
membrane protein
Membrane proteins
membranes
NBD, nitrobenzoxadiazole
NIH, National Institutes of Health
Particle
Pathogenesis
plasma membrane
Polymer
progeny
Protein
purification
recombinant
S2-E-NBD, NBD-labeled S2-E
S2-E, SARS-CoV-2 envelope protein
SARS
SARS-CoV-2 envelope
SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2
TGN, trans -Golgi network
trans-Golgi network
vesicles
WGA, wheat germ agglutinin
[DOI] 10.1016/j.jbc.2021.100940 PMC 바로가기 [Article Type] Accelerated Communication
[DOI] 10.1016/j.jbc.2021.100940 PMC 바로가기 [Article Type] Accelerated Communication